Transpara® Breast AI

FDA, CE & Health Canada | Breast | DBT & FFDM | Amplifier Partner

Description of use

Transpara® Breast AI analyzes 2D full-field digital mammography (FFDM) and 3D digital breast tomosynthesis (DBT) to support radiologists in earlier breast cancer detection and mammography workflows. Transpara identifies suspicious calcifications and soft-tissue findings, provides region-level findings and an exam-level risk category, and helps radiologists recognize low-risk examinations, prioritize higher-risk studies, and focus attention on suspicious areas. Backed by 55+ peer-reviewed publications and randomized controlled trial evidence, Transpara delivers clinically validated AI support.

The application content is provided by the respective AI vendors.